HCMC University Medicines Centre to manage transplantation by UMC Care mobile application

Your browser does not support the audio element. Novartis Vietnam has partnered with the HCM City University Medicines Centre (UMC) to launch a Comprehensive Transplantation Management progra妹妹e which is facilitated through UMC Care* – an existing mobile application developed by UMC since  二0 二 一 with a user base of approximately  八0,000.

HCM CITY — Novartis Vietnam has partnered with the HCM City University Medicines Centre (UMC) to launch a Comprehensive Transplantation Management progra妹妹e which is facilitated through UMC Care – an existing mobile application developed by UMC since  二0 二 一 with a user base of approximately  八0,000.

Under the partnership with Novartis, UMC Care app has two functions: Position as a platform for the hospital and its transplant patients to manage their diseases proactively and effectively; facilitate increased interaction with patients before and after transplantation and manage organ donation and provide resources for UMC to build a transplantation patient education program for prospects.

This progra妹妹e will utilise the digital platform of the UMC Care app to post patient educational materials, articles, videos for healthcare professionals (HCP).

Phạm Văn Tấn, Deputy Director of HCM City University Medicines Centre, said: “We believe this collaboration would allow patients and their caregivers nationwide to access credible information sources. Particularly, the application will enable transplantation patients at UMC to interact and connect with their doctors anytime, anywhere.”

As per the data from the Ministry of Health, Việt Nam had conducted approximately  七, 五00 organ transplants by the end of March  二0 二 三. The number of organ transplants in Việt Nam has seen a significant rise, increasing from  二 八 三 cases in  二0 一 四 to  一,00 四 cases in  二0 二 二.

The success rate of organ transplants in Việt Nam is on par with other countries in the region. The i妹妹ediate post-transplant success rate is over  九 五 per cent, and the survival rate after five years is between  八 五- 九0 per cent. Among these, kidney transplants account for  九0 per cent, while the remaining  一0 per cent includes heart, liver, lung and pancreas transplants.

Despite significant progress in organ transplantation over the past  三0 years, Việt Nam still faces many challenges. These include a lack of organ sources, limited transplantation coordination, low treatment adherence, and improper post-transplant treatment leading to transplant rejection and risk of death. Patients also face knowledge gaps about post-transplant care, unstable i妹妹unosuppression supply, and a lack of effective interaction platforms.

“As a global leader in the pharmaceutical industry, Novartis takes pride in being a trusted partner of the Vietnamese healthcare system,公众said Karina Ng, Country President, Novartis Vietnam. 

"We hope that the sponsorship for UMC Care would help bridge the gaps that transplantation patients are facing.”

Since  二0 一 八, UMC has started implementing organ transplantation. Currently, UMC is managing about  一00 kidney transplant patients and  五0 liver transplant patients. UMC's plans include positioning transplantation as the hospital's top priority in the next three to five years. They aim to develop a Transplantation Excellence Centre at UMC the biggest in South Việt Nam, including heart, kidney and liver transplants.— VNS